Cargando…
An Optimized Single Nucleotide Polymorphism-Based Detection Method Suggests That Allelic Variants in the 3’ Untranslated Region of RRAS2 Correlate with Treatment Response in Chronic Lymphocytic Leukemia Patients
SIMPLE SUMMARY: Overexpression of unmutated RRAS2 could be behind the development of chronic lymphocytic leukemia (CLL). This is, in part, supported by the presence of a single-nucleotide polymorphism (SNP) in the 3’ untranslated region of the RRAS2 mRNA that is linked to higher RRAS2 overexpression...
Autores principales: | Hortal, Alejandro, Lacuna, Marta, Cifuentes, Claudia, Alcoceba, Miguel, Bustelo, Xosé R., González, Marcos, Alarcón, Balbino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913312/ https://www.ncbi.nlm.nih.gov/pubmed/36765602 http://dx.doi.org/10.3390/cancers15030644 |
Ejemplares similares
-
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
por: Hortal, Alejandro M., et al.
Publicado: (2022) -
RRas2, RhoG and T-cell phagocytosis
por: Alarcón, Balbino, et al.
Publicado: (2012) -
RRAS2 shapes the TCR repertoire by setting the threshold for negative selection
por: Martínez-Riaño, Ana, et al.
Publicado: (2019) -
In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathies
por: van Engelen, Nienke, et al.
Publicado: (2022) -
Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
por: Flex, Elisabetta, et al.
Publicado: (2014)